GSK could find itself blacklisted under China’s new anti-bribery rules
SHANGHAI – China has issued two legal announcements in its bid to root out corruption in the pharmaceutical industry. They focus on both the demand and supply side of corruption in China, targeting pharma companies that pay bribes and the doctors who accept them.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST